- Home
- HCTI vs EDSA Comparison
HCTI vs EDSA Comparison
Compare HCTI & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCTI | EDSA |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5M | 12.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HCTI | EDSA |
|---|---|---|
| Price | $2.26 | $1.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 247.5K | 30.2K |
| Earning Date | 11-13-2025 | 12-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,942,000.00 | N/A |
| Revenue This Year | $47.01 | N/A |
| Revenue Next Year | $44.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.37 | $1.55 |
| 52 Week High | $435.75 | $4.49 |
Technical Indicators
Market Signals| Indicator | HCTI | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 48.89 | 38.18 |
| Support Level | $2.06 | $1.67 |
| Resistance Level | $2.41 | $1.78 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 71.64 | 31.21 |
Price Performance
Historical ComparisonAbout HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.